BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21844373)

  • 1. Structural basis of simultaneous recruitment of the transcriptional regulators LMO2 and FOG1/ZFPM1 by the transcription factor GATA1.
    Wilkinson-White L; Gamsjaeger R; Dastmalchi S; Wienert B; Stokes PH; Crossley M; Mackay JP; Matthews JM
    Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14443-8. PubMed ID: 21844373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
    El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
    Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
    Draheim KM; Hermance N; Yang Y; Arous E; Calvo J; Kelliher MA
    Oncogene; 2011 Mar; 30(10):1252-60. PubMed ID: 21057528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification, crystallization and preliminary X-ray analysis of a fusion of the LIM domains of LMO2 and the LID domain of Ldb1.
    El Omari K; Porcher C; Mancini EJ
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Nov; 66(Pt 11):1466-9. PubMed ID: 21045296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.
    Visvader JE; Mao X; Fujiwara Y; Hahm K; Orkin SH
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13707-12. PubMed ID: 9391090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ldb1 complexes: the new master regulators of erythroid gene transcription.
    Love PE; Warzecha C; Li L
    Trends Genet; 2014 Jan; 30(1):1-9. PubMed ID: 24290192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins.
    Wadman IA; Osada H; Grütz GG; Agulnick AD; Westphal H; Forster A; Rabbitts TH
    EMBO J; 1997 Jun; 16(11):3145-57. PubMed ID: 9214632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation.
    Xu Z; Huang S; Chang LS; Agulnick AD; Brandt SJ
    Mol Cell Biol; 2003 Nov; 23(21):7585-99. PubMed ID: 14560005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple functions of Ldb1 required for beta-globin activation during erythroid differentiation.
    Song SH; Kim A; Ragoczy T; Bender MA; Groudine M; Dean A
    Blood; 2010 Sep; 116(13):2356-64. PubMed ID: 20570862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of disease-causing GATA1 mutations in murine gene complementation systems.
    Campbell AE; Wilkinson-White L; Mackay JP; Matthews JM; Blobel GA
    Blood; 2013 Jun; 121(26):5218-27. PubMed ID: 23704091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dynamic emergence of GATA1 complexes identified in
    Yu X; Martella A; Kolovos P; Stevens M; Stadhouders R; Grosveld FG; Andrieu-Soler C
    Haematologica; 2020 Jul; 105(7):1802-1812. PubMed ID: 31582556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
    Gering M; Yamada Y; Rabbitts TH; Patient RK
    Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-stranded DNA-binding proteins regulate the abundance of LIM domain and LIM domain-binding proteins.
    Xu Z; Meng X; Cai Y; Liang H; Nagarajan L; Brandt SJ
    Genes Dev; 2007 Apr; 21(8):942-55. PubMed ID: 17437998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Building multifunctionality into a complex containing master regulators of hematopoiesis.
    Fujiwara T; Lee HY; Sanalkumar R; Bresnick EH
    Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20429-34. PubMed ID: 21059912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCL assembles a multifactorial complex that determines glycophorin A expression.
    Lahlil R; Lécuyer E; Herblot S; Hoang T
    Mol Cell Biol; 2004 Feb; 24(4):1439-52. PubMed ID: 14749362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, production and characterization of FLIN2 and FLIN4: the engineering of intramolecular ldb1:LMO complexes.
    Deane JE; Sum E; Mackay JP; Lindeman GJ; Visvader JE; Matthews JM
    Protein Eng; 2001 Jul; 14(7):493-9. PubMed ID: 11522923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the recognition of ldb1 by the N-terminal LIM domains of LMO2 and LMO4.
    Deane JE; Mackay JP; Kwan AH; Sum EY; Visvader JE; Matthews JM
    EMBO J; 2003 May; 22(9):2224-33. PubMed ID: 12727888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A positive role for NLI/Ldb1 in long-range beta-globin locus control region function.
    Song SH; Hou C; Dean A
    Mol Cell; 2007 Dec; 28(5):810-22. PubMed ID: 18082606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCL and associated proteins distinguish active from repressive GATA transcription factor complexes.
    Tripic T; Deng W; Cheng Y; Zhang Y; Vakoc CR; Gregory GD; Hardison RC; Blobel GA
    Blood; 2009 Mar; 113(10):2191-201. PubMed ID: 19011221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.